Both in Pharmaceuticals
Elicio Therapeutics vs Serina Therapeutics
Over the past year ELTX returned −81.0% and SER returned −67.8%; their daily moves had a correlation of -0.02.
ELTX −81.0% SER −67.8%Growth of $1, one year, split-adjusted
| Metric | ELTX | SER |
|---|---|---|
| Price | $1.85 | $1.64 |
| Market cap | $50.1M | $41.7M |
| Today | +1.09% | −1.80% |
| 1 month | +0.5% | −21.2% |
| 6 months | −82.1% | −10.4% |
| Year to date | −76.8% | −14.3% |
| 1 year | −80.9% | −67.7% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $13.9M | $19.9M |
| Dividend yield | — | — |
| Volatility (60d) | 67.9% | 73.3% |
| Short % of float | 20.8% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).